An A/B Dose Escalation Study of AbGn-7 Alone and With FOLFOX7 Treatment in Patients With Advanced Solid Tumors

NCT01466569 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor of Epithelial Origin
Gastric Cancer

Interventions

DRUG: AbGn-7
DRUG: AbGn-7

Sponsor

AbGenomics B.V Taiwan Branch